Siemens Healthineers acquired Corindus for $1.1 billion in 2019. Corindus develops the CorPath robot-assisted device for coronary and peripheral vascular procedures.
technIQ software for Corindus CorPath GRX surgical robot receives FDA approval
Corindus said new motion automations have received FDA clearance for use in coronary and peripheral robotic-assisted procedures.
Remote surgeries, brain procedures demonstrate Corindus CorPath GRX advances
Doctor have now used the CorPath GRX system in a successful brain surgery and to conduct multiple remote surgeries, advancing the state of robot-assisted procedures.
Telesurgery trials mark milestone in India; doctors discuss lessons
A cardiac surgeon in India and one in the U.S. discuss promising developments and remaining challenges around robot-assisted telesurgery.
Remote surgery using robots advances with 5G tests in China
One of the most promising uses of 5G networking technology is in robotic remote surgery. China has led the way with several demonstrations, adding to U.S. concerns about international competitiveness.
Corindus Vascular Robotics to be acquired by Siemens Medical Solutions for $1.1B
Corindus Vascular Robotics, whose CorPath GRX has FDA approval for percutaneous coronary and vascular procedures, will be acquired by Siemens Healthineers.
Corindus submits CorPath GRX to FDA for robotic neurovascular interventions
Corindus Vascular Robotics this week said it applied to the U.S. Food and Drug Administration for premarket clearance to use its CorPath GRX robotic surgical platform in neurovascular interventions. The Waltham, Mass.-based company has already received FDA clearance for percutaneous coronary interventions (PCI), which it won in 2016, and for peripheral vascular interventions (PVI), which it won last…
CorPath GRX Robotic Center educates physicians on robotics in healthcare
Corindus Vasular Robotics opened its first international CorPath GRX Robotic Center in Tokyo to educate cardiologists on robotic-assisted percutaneous coronary interventions, the company announced today. “The opening of the first international robotic center represents an important milestone in the process of bringing precision vascular robotics to patients and physicians in Japan and around the world,”…
Corindus launches post-approval study for CorPath GRX coronary system
Corindus Vascular Robotics announced the first patient enrollment in a post-market study of its second-generation CorPath GRX System, a robot-assisted system for percutaneous coronary interventions such as stenting. “Enrollment of the first patient in the Precision GRX registry is a major milestone for the company and we look forward to the participation of leading centers…
7 medtech stories we missed this week: March 31, 2017
This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia. Here are 7 medtech stories we missed this week but thought were still worth mentioning: 1. Corindus touts first Asian use of next-generation robot Corindus Vascular Robotics announced in a March 31 press…